UPDATE: GlaxoSmithKline (GSK) Reports Q1 EPS of 25P
Tweet
Share
E-mail
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
(Updated - April 26, 2017 7:10 AM EDT)
GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of GBP0.25. Revenue for the quarter came in at GBP7.4 billion.
Q1 2017 results | |||||
| Q1 2017 |
| Growth | ||
| £m |
| £% |
| CER% |
|
|
|
|
|
|
Turnover | 7,384 |
| 19 |
| 5 |
|
|
|
|
|
|
Total operating profit | 1,718 |
| >100 |
| 100 |
Adjusted operating profit | 1,979 |
| 30 |
| 9 |
|
|
|
|
|
|
Total earnings per share | 21.4 |
| >100 |
| >100 |
Adjusted earnings per share | 25.0 |
| 31 |
| 9 |
|
|
|
|
|
|
Net cash from operations | 1,144 |
| >100 |
|
|
Free cash flow | 650 |
| >100 |
|
|
|
|
|
|
|
|
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
- Goldman Sachs Upgrades Amorepacific Corp (090430:KS) (AMRPF) to Buy
- Hershey (HSY) PT Lowered to $200 at Piper Sandler
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
